Top Policy and Practice News of 2024
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in cardiology this year.
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in cardiology this year.
This cross-sectional study evaluates the association of BAG3 genetic variation with penetrance and longitudinal outcomes of dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).
In patients with narrow QRS complex, both ventricular and biventricular pacing is associated with increased cardiac morbidity and mortality. This risk is not decreased by…
This small study suggests there’s much still to learn about how best to handle the complexity of repeat procedures.
This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo…
Gratitude is good medicine. Learn how a regular gratitude practice can make you healthier and what great things it can lead to.
Echocardiologist & Interventionist join: whether you practice in a heart valve disease clinic or cardiac cathlab, discover this dynamic 2-day imaging workshop focused on valve…
Welcome to cardiology’s jolliest—and most socially acceptable forum—for proving you paid attention to the top news of 2024! Submit your crossword answers, whether you’ve answered…
This is a terrific healthy American dinner that will help you up your veggie intake for the day.
Space is limited, so hurry to sign up for the 2-day workshop taking place onsite in Madrid, on 2-3 February, 2024.
In a pivotal trial (NCT05252702), the AVEIR DR (Abbott) leadless pacemaker system was found to be safe and effective in delivering DDDR synchronous atrial and…